These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Determination of the dose-response curve of a new hypolipidemic molecule: tibric acid (CP-18524). Methodologic and statistical aspects]. Bielmann P; Annable L; Brun D; Moorjani S; Lupien PJ; Tétreault L Union Med Can; 1975 Jun; 104(6):930-4. PubMed ID: 1224412 [No Abstract] [Full Text] [Related]
6. [Clinical experimentation with a new drug lowering blood lipids (Tiadenol)]. Potì R; Quintavalla R; Manotti C G Clin Med; 1977; 58(7-8):293-300. PubMed ID: 336442 [No Abstract] [Full Text] [Related]
7. Coronary revascularization and aggressive lipid lowering. Pershad A; Kratzer S; Cooper A J Invasive Cardiol; 1999 Feb; 11(2):87-9. PubMed ID: 10745488 [No Abstract] [Full Text] [Related]
13. Improvement in current approaches to lipid lowering. Ansell BJ Am Fam Physician; 2002 Mar; 65(5):783, 786-7. PubMed ID: 11898952 [No Abstract] [Full Text] [Related]
14. Relation of the use of lipid-lowering medications prior to percutaneous coronary intervention to the incidence of intraprocedural adverse angiographic events. Ferguson MA; Romick BG; Carter LI; De Geare VS Am J Cardiol; 2005 Apr; 95(8):978-80. PubMed ID: 15820168 [TBL] [Abstract][Full Text] [Related]
15. Achieving lipid goals in Europe: how large is the treatment gap? Schwandt P; Brady AJ Expert Rev Cardiovasc Ther; 2004 May; 2(3):431-49. PubMed ID: 15151488 [TBL] [Abstract][Full Text] [Related]
16. [MPPG complex belongs in the first phase of drug-assisted lipid lowering (magnesium-pyridoxal-phosphate-glutamate )]. Wieland H Fortschr Med; 1990; 108 Spec No 1():52-3. PubMed ID: 2245961 [No Abstract] [Full Text] [Related]
17. A vote of no confidence in the precision of the estimated cost-effectiveness of lipid lowering. Wilcock M Br J Gen Pract; 2000 Nov; 50(460):917-8. PubMed ID: 11141882 [No Abstract] [Full Text] [Related]
18. Statin use in a "real-world" clinical setting: aggressive lipid lowering compared with usual care in the Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE) trial. Koren MJ Am J Med; 2005 Dec; 118 Suppl 12A():16-21. PubMed ID: 16356803 [TBL] [Abstract][Full Text] [Related]
19. [Guidelines for lipid-lowering therapy. Results of the 2d Consensus Conference of the European Atherosclerosis Society. Press conference. London, 6 May 1988]. Fortschr Med Suppl; 1988; 46():1-22. PubMed ID: 2905324 [No Abstract] [Full Text] [Related]
20. Three new drugs for hyperlipidemia. Conn Med; 2003 May; 67(5):279-81. PubMed ID: 12802842 [No Abstract] [Full Text] [Related] [Next] [New Search]